Skip to content

Single arm study to see the effect of prapunnadadi lepa in dadru kushta

Single arm clinical study to assess the efficacy of Prapunnadadi Lepa in the management of Dadru Kushta. - NIL

Status
Active, not recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/07/071233
Enrollment
35
Registered
2024-07-24
Start date
Unknown
Completion date
Unknown
Last updated
2024-08-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L088- Other specified local infections of the skin and subcutaneous tissue

Interventions

None listed

Sponsors

Dr Amruta Ramesh Rajmane
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1)Patients diagnosed as Dadru Kushta as per sign and symptoms which are mention in Ayurvedic Samhita. 2)Gender-Irrespective of gender and socioeconomic status. 3)Age-Above 18 to 60 years.

Exclusion criteria

Exclusion criteria: 1)Pregnant women and lactating women. 2)Less than 18 years and more than 60 years. 3)Mandal with secondary infection & immuno suppressive. 4)Mandal more than 7 in number. 5)Mandal measuring above 10 cm in length and above 10 cm in breadth.

Design outcomes

Primary

MeasureTime frame
To Study the effect of Prapunnadadi Lepa in the management of Dadru Kushta.Timepoint: 10 days

Secondary

MeasureTime frame
1)To study Dadru Kushta in Ayurvedic perspective. 2)To study Prapunnadadi Lepa in detail in Dadru Kushta. 3)To study the efficacy of Prapunnadadi Lepa in Dadru Kushta.Timepoint: 10 days

Countries

India

Contacts

Public ContactDr Amruta Ramesh Rajmane

LRP Ayurvedic medical college and hospital, PG Institute and Research center, Urun Islampur Sangli

drabhinandanpatil@gmail.com9890205000

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026